Page 204 - Read Online

Page 8 of 10 Berezin. Vessel Plus 2018;2:22 I http://dx.doi.org/10.20517/2574-1209.2018.23

24. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM. Bone marrow origin of endothelial
progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85:221-8.
25. Murohara T. Angiogenesis and vasculogenesis for therapeutic neovascularization. Nagoya J Med Sci 2003;66:1-7.
26. Charlene A. McQueen, editor-in-chief. Comprehensive toxicology. Amsterdam: Elsevier Science; 2018. p. 130-82.
27. Böldicke T, Tesar M, Griesel C, Rohde M, Gröne HJ, Waltenberger J, Kollet O, Lapidot T, Yayon A, Weich H. Anti-VEGFR-2 scFvs
for cell isolation. Single-chain antibodies recognizing the human vascular endothelial growth factor receptor-2 (VEGFR-2/flk-1) on the
surface of primary endothelial cells and preselected CD34+ cells from cord blood. Stem Cells 2001;19:24-36.
28. Ferreras C, Cole CL, Urban K, Jayson GC, Avizienyte E. Segregation of late outgrowth endothelial cells into functional endothelial
CD34- and progenitor-like CD34+ cell populations. Angiogenesis 2015;18:47-68.
29. Popa ER, Harmsen MC, Tio RA, van der Strate BW, Brouwer LA, Schipper M, Koerts J, De Jongste MJ, Hazenberg A, Hendriks M, van
Luyn MJ. Circulating CD34+ progenitor cells modulate host angiogenesis and inflammation in vivo. J Mol Cell Cardiol 2006;41:86-96.
30. Xu QB. Endothelial progenitor cells in angiogenesis. Sheng Li Xue Bao 2005;57:1-6.
31. Hristov M, Erl W, Weber PC. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol
2003;23:1185-9.
32. Iwaguro H, Yamaguchi J, Kalka C, Murasawa S, Masuda H, Hayashi S, Silver M, Li T, Isner JM, Asahara T. Endothelial progenitor cell
vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 2002;105:732-8.
33. Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, Murasawa S, Bosch-Marce M, Masuda H, Losordo DW, Isner JM, Asahara
T. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization.
Circulation 2003;107:1322-8.
34. Hiasa K, Ishibashi M, Ohtani K, Inoue S, Zhao Q, Kitamoto S, Sata M, Ichiki T, Takeshita A, Egashira K. Gene transfer of stromal cell-
derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide
synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation 2004;109:2454-61.
35. Pasut A, Chang NC, Gurriaran-Rodriguez U, Faulkes S, Yin H, Lacaria M, Ming H, Rudnicki MA. Notch signaling rescues loss of
satellite cells lacking Pax7 and promotes brown adipogenic differentiation. Cell Rep 2016;16:333-43.
36. Kachamakova-Trojanowska N, Bukowska-Strakova K, Zukowska M, Dulak J, Jozkowicz A. The real face of endothelial progenitor
cells - circulating angiogenic cells as endothelial prognostic marker? Pharmacol Rep 2015;67:793-802.
37. Fang S, Wei J, Pentinmikko N, Leinonen H, Salven P. Generation of functional blood vessels from a single c-kit+ adult vascular
endothelial stem cell. PLoS Biol 2012;10:e1001407.
38. Ingram DA, Mead LE, Moore DB, Woodard W, Fenoglio A, Yoder MC. Vessel wall-derived endothelial cells rapidly proliferate because
they contain a complete hierarchy of endothelial progenitor cells. Blood 2005;105:2783-6.
39. Yoder MC. Is endothelium the origin of endothelial progenitor cells? Arterioscler Thromb Vasc Biol 2010;30:1094-103.
40. Berezin AE. Biomarkers for cardiovascular risk in patients with diabetes. Heart 2016;102:1939-41.
41. Qu K, Wang Z, Lin XL, Zhang K, He XL, Zhang H. MicroRNAs: key regulators of endothelial progenitor cell functions. Clin Chim
Acta 2015;448:65-73.
42. Berezin AE, Kremzer AA, Berezina TA, Martovitskaya YV. The pattern of circulating microparticles in patients with diabetes mellitus
with asymptomatic atherosclerosis. Acta Clin Belg 2016;71:38-45.
43. Berezin AE, Kremzer AA, Berezina TA, Martovitskaya YV, Gronenko EA. Data regarding association between serum osteoprotegerin
level, numerous of circulating endothelial-derived and mononuclear-derived progenitor cells in patients with metabolic syndrome. Data
Brief 2016;8:717-22.
44. Berezin AE, Samura TA, Kremzer AA, Berezina TA, Martovitskaya YV, Gromenko EA. An association of serum vistafin level and
number of circulating endothelial progenitor cells in type 2 diabetes mellitus patients. Diabetes Metab Syndr 2016;10:205-12.
45. Berezin AE, Kremzer AA. Relationship between circulating endothelial progenitor cells and insulin resistance in non-diabetic patients
with ischemic chronic heart failure. Diabetes Metab Syndr 2014;8:138-44.
46. Berezin AE, Kremzer AA, Samura TA, Berezina TA, Kruzliak P. Impaired immune phenotype of circulating endothelial-derived
microparticles in patients with metabolic syndrome and diabetes mellitus. J Endocrinol Invest 2015;38:865-74.
47. Bakogiannis C, Tousoulis D, Androulakis E, Briasoulis A, Papageorgiou N, Vogiatzi G, Kampoli AM, Charakida M, Siasos G, Latsios G,
Antoniades C, Stefanadis C. Circulating endothelial progenitor cells as biomarkers for prediction of cardiovascular outcomes. Curr Med
Chem 2012;19:2597-604.
48. Berezin AE, Kremzer AA. Circulating endothelial progenitor cells as markers for severity of ischemic chronic heart failure. J Card Fail
2014;20:438-47.
49. Berezin AE, Kremzer AA, Samura TA, Berezina TA, Martovitskaya YV. Serum uric Acid predicts declining of circulating proangiogenic
mononuclear progenitor cells in chronic heart failure patients. J Cardiovasc Thorac Res 2014;6:153-62.
50. Mohandas R, Segal MS. Endothelial progenitor cells and endothelial vesicles - what is the significance for patients with chronic kidney
disease? Blood Purif 2010;29:158-62.
51. Fadini GP, Sartore S, Baesso I, Lenzi M, Agostini C, Tiengo A, Avogaro A. Endothelial progenitor cells and the diabetic paradox.
Diabetes Care 2006;29:714-6.
52. Tan K, Lessieur E, Cutler A, Nerone P, Vasanji A, Asosingh K, Erzurum S, Anand-Apte B. Impaired function of circulating CD34(+)
CD45(-) cells in patients with proliferative diabetic retinopathy. Exp Eye Res 2010;91:229-37.
53. Lombardo MF, Iacopino P, Cuzzola M, Spiniello E, Garreffa C, Ferrelli F, Coppola A, Saccardi R, Piaggesi A, Piro R, Mannino D,
Grossi G, Lauro D, Irrera G. Type 2 diabetes mellitus impairs the maturation of endothelial progenitor cells and increases the number of